CTO

CTO Operating Expenses

-$60.19MTTM · USD

Period ending:

CTO FY Operating ExpensesUSD
CTO FY Operating Expenses1985-12-31: $3.80M1986-12-31: $3.60M1987-12-31: $34.60M1988-12-31: $42.40M1989-12-31: $4.50M1990-12-31: $5.00M1991-12-31: $6.00M1992-12-31: $5.20M1993-12-31: $5.40M1994-12-31: $4.60M1995-12-31: $4.60M1996-12-31: $4.50M1997-12-31: $6.80M1998-12-31: $2.50M1999-12-31: $3.20M2000-12-31: $3.36M2001-12-31: $4.59M2002-12-31: -$1.61M2003-12-31: -$1.75M2004-12-31: -$1.21M2005-12-31: -$1.21M2006-12-31: -$1.25M2007-12-31: -$3.24M2008-12-31: -$2.08M2009-12-31: $2.77M2010-12-31: $3.91M2011-12-31: $6.09M2012-12-31: $8.93M2013-12-31: $8.32M2014-12-31: $10.51M2015-12-31: $13.97M2016-12-31: $18.49M2017-12-31: $22.92M2018-12-31: $25.55M2019-12-31: $3.64M2020-12-31: $28.89M2021-12-31: $24.50M2022-12-31: $41.75M2023-12-31: $52.44M2024-12-31: $73.69M2025-12-31: -$41.49M$73.69M-$41.49M
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CTO operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Cto Realty Growth Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
-41,488,000
73,686,000
52,435,000
41,754,000
24,497,000
28,890,000
3,637,000
25,546,893
22,916,569
18,493,294
13,966,676
10,507,721
8,318,879
8,932,619
6,089,133
3,914,218
2,771,633
-2,082,192
-3,243,058
-1,253,050
-1,210,272
-1,213,420
-1,745,949
-1,614,685
4,594,330
3,364,792
3,200,000
2,500,000
6,800,000
4,500,000
4,600,000
4,600,000
5,400,000
5,200,000
6,000,000
5,000,000
4,500,000
42,400,000
34,600,000
3,600,000
3,800,000

Compare operating expenses

All CTO financial metrics · CTO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.